Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cigna    CI

CIGNA (CI)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CET

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; [email protected]

Stocks mentioned in the article : CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA
01/10 CIGNA : Kim Shepard Named Cigna Market President for Arizona Health Plans
01/09 CIGNA CORP : Regulation FD Disclosure (form 8-K)
01/05 CIGNA CORPORATION : ’s Fourth Quarter 2017 Earnings Release Details
2017 CIGNA CORPORATION : Announces Appearance at the 36th Annual J.P. Morgan Healthca..
2017 CIGNA : CI) Share Value Rose, Investec Asset Management LTD Boosted Position by ..
2017 CIGNA : Investec Asset Management LTD Has Boosted Holding in Cigna Corp (CI)
2017 CIGNA CORP : Creation of a Direct Financial Obligation or an Obligation under an..
2017 Humana, private equity firms buy Kindred Healthcare for $810 million
2017 CIGNA CORPORATION : Announces Appearance at the 36th Annual J.P. Morgan Healthca..
2017 CIGNA : Acquires Brighter, a Leader in Digital Engagement of Health Care Consume..
More news
News from SeekingAlpha
01/17 UnitedHealth's Q4 beat buoys peers
01/10 Demographic Delusions - A Different Look At Skilled Nursing And Healthcare RE..
01/03 More new coverage - healthcare
2017 The 12 Sells Of Christmas
2017 CVS to finance Aetna deal with $65.8B in new debt and equity; shares down 5%
Financials ($)
Sales 2017 41 225 M
EBIT 2017 3 706 M
Net income 2017 2 450 M
Debt 2017 1 032 M
Yield 2017 0,02%
P/E ratio 2017 23,10
P/E ratio 2018 18,91
EV / Sales 2017 1,34x
EV / Sales 2018 1,29x
Capitalization 54 278 M
Chart CIGNA
Duration : Period :
Cigna Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 229 $
Spread / Average Target 4,2%
EPS Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA8.50%54 278
UNITEDHEALTH GROUP8.15%235 285
ANTHEM INC10.73%64 206
AETNA2.61%61 242
HUMANA11.16%39 901
CENTENE CORPORATION10.38%19 098